ICAAC 52nd (2012)

Title Content type
In vitro activity of Isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (click for details)
In Vitro Activity of Isavuconazole Against Cryptococcus Isolates – A Pooled Analysis of 3 Studies (click for details)
Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of CYP3A4 Substrate Midazolam in Healthy Volunteers (click for details)
Isavuconazole (ISA) Pharmacodynamic (PD) Target Determination for C. albicans (CA) in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
Aspergillus RNA In The Blood Of Patients Is A Promising Alternative Biomarker For Invasive Aspergillosis (click for details)
Intra-abdominal Candidiasis (IAC) Is Under-recognized, But Is The Most Common Type Of Invasive Candidiasis (IC) And Results In Poor Outcomes (click for details)
Efficacy and Dose-Response Relationships of Liposomal Amphotericin B (L-AmB) against Different Azole-Resistant Aspergillus fumigatus Isolates in a Non-Neutropenic Murine Model of Disseminated Aspergillosis (click for details)
Efficacy of Anidulafungin in Patients with Invasive Candidiasis (IC): Focus on non-albicans Candida spp (click for details)
A Point Prevalence Survey (PPS) of Neonatal and Paediatric Antifungal Use in Europe (click for details)
Epidemiology, Clinical Manifestations, Management and Outcome of 179 Cases of Aspergillus Osteomyelitis (click for details)


Subscribe to ICAAC 52nd (2012)